Obesity Therapy
Rosiglitazone-induced benefits to insulin sensitivity seem to be linked to edema formation
Published in Drug Week, April 28th, 2006
"The use of thiazolidinedione (TZD) derivatives is associated with fluid retention, especially when combined with insulin. Because TZDs improve the metabolic effect of insulin, they may also reverse the blunted vascular response to insulin. We hypothesize that improvement of the action of insulin on vascular tone or permeability is the key mechanism of TZD-related fluid retention," researchers in Netherlands report.
A.J.M. Rennings and colleagues at Radboud University conducted "a randomized, double-blind, placebo-controlled, cross-over study in 18...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Drug Week
Source: Drug Week (2006-04-28)
More Articles from Drug Week
- Drug Development
Nitric oxide-donating aspirin is focus of review of pharmacological and clinical perspectives - Drug Development
Paclitaxel efficacy enhanced by novel compound 73R - Drug Development
Rifamycin-resistant Staphylococcus aureus susceptible to novel rifamycins - HIV/AIDS HAART
HAART discontinuation risk factors identified - Melanoma Therapy
Preclinical results support continued evaluation of CR011-vcMMAE for melanoma - Acid Reflux
Gastroesophageal acid reflux Rennie alginate treatment promising - More from this issue of Drug Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
